Last reviewed · How we verify

Urinary Human follicle stimulating hormone

Instituto Bernabeu · FDA-approved active Small molecule Quality 5/100

Urinary Human follicle stimulating hormone is a Small molecule drug developed by Instituto Bernabeu. It is currently FDA-approved. Also known as: Daily injections of gonadotropins.

At a glance

Generic nameUrinary Human follicle stimulating hormone
Also known asDaily injections of gonadotropins
SponsorInstituto Bernabeu
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Urinary Human follicle stimulating hormone

What is Urinary Human follicle stimulating hormone?

Urinary Human follicle stimulating hormone is a Small molecule drug developed by Instituto Bernabeu.

Who makes Urinary Human follicle stimulating hormone?

Urinary Human follicle stimulating hormone is developed and marketed by Instituto Bernabeu (see full Instituto Bernabeu pipeline at /company/instituto-bernabeu).

Is Urinary Human follicle stimulating hormone also known as anything else?

Urinary Human follicle stimulating hormone is also known as Daily injections of gonadotropins.

What development phase is Urinary Human follicle stimulating hormone in?

Urinary Human follicle stimulating hormone is FDA-approved (marketed).

Related